“We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic
source: pixabay.com

“We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic

When Lucinka was born, it seemed like everything was all right. But it wasn’t. Lucinka wasn’t doing well, and a whirlwind of examinations began. First, a diagnosis couldn’t be made.…

Continue Reading “We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic
After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
jarmoluk / Pixabay

After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease

According to a story from Wales Online, Samantha Josey's childhood was characterized by unpleasant symptoms and health problems, resulting in hospital visits and bouts of serious illness. Her symptoms included…

Continue Reading After a Childhood Plagued by Illness, This Woman Was Finally Diagnosed With Mitochondrial Disease
Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
argzombies / Pixabay

Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease

According to a story from clinicaltrials.gov, the Children's Hospital of Philadelphia is sponsoring a study that has the potential to make mitochondrial disease research and drug development much easier. The…

Continue Reading Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment
source: pixabay.com

Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment

According to a publication from Business Wire, the Israeli biotechnology company Minovia Therapeutics recently finished dosing the first participant in a phase I/II clinical study of the Company's experimental mitochondrial…

Continue Reading Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment
Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease
geralt / Pixabay

Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease

According to a story from Wellcome Center Mitochondrial Research, a multi-center collaborative study that involved researchers from different sites around the UK has resulted in an improved understanding of the…

Continue Reading Study Identifies Broader Range of Clinical Presentation for Mitochondrial Disease

The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

PREFER PREFER stands for Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle. It is a multi-stage project developed by Newcastle University's Welcome Centre for Mitochondrial Research in effort…

Continue Reading The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research
New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease
source: pixabay.com

New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease

According to a story from news-medical.net, a recent study has reshaped the scientific understanding of the origins of mitochondrial disease. For decades any mutation that affected the mitochondrial DNA and…

Continue Reading New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease
Kidney Disease Drug May Have Future Treating Mitochondrial Disorders
argzombies / Pixabay

Kidney Disease Drug May Have Future Treating Mitochondrial Disorders

A publication at Science Daily recently announced that findings from Children's Hospital of Philadelphia suggested that cysteamine bitartrate, already used for nephropathic cystinosis (a rare kidney disease), might potentially benefit patients…

Continue Reading Kidney Disease Drug May Have Future Treating Mitochondrial Disorders
Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
argzombies / Pixabay

Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

According to a story from BioSpace, the biopharmaceutical company Modis Therapeutics recently announced that the US Food and Drug Administration (FDA) has granted Breakthough Therapy designation for the company's experimental…

Continue Reading Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases

According to a story from UPI, gene editing technology could be a potential treatment for mitochondrial diseases, a rare, genetic illness that is usually fatal. In a proof-of-concept experiment, researchers…

Continue Reading Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases